We need your help now
Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
Sign in. It’s quick, free and it’s up to you.
An account is an optional way to support the work we do. Find out more.
By continuing, you are indicating that you accept our Terms of Service and Privacy Policy.
THE EU’S MEDICINES watchdog has recommended that Pfizer/BioNTech’s anti-Covid booster vaccine be approved for children aged 12 and older.
The “EMA’s human medicines committee (CHMP) has recommended that a booster dose of the Covid-19 vaccine Comirnaty may be given where appropriate to adolescents from 12 years of age,” the European Medicines Agency said in a statement, using the vaccine’s brand name.
“The committee considered that the available evidence was sufficient to conclude that the immune response to a booster dose in adolescents would be at least equal to that in adults”, it added.
The Amsterdam-based EMA earlier this month said it was evaluating the application to use Comirnaty within the 27-member bloc.
The EMA’s opinion will now be sent to the European Commission “to issue a final decision shortly”, it said.
However, it will be up to each individual member state to decide whether to implement the booster campaign for children this age.
This would be based on factors such as “the spread and likely severity of the disease in younger persons, the known risk of side effects and the existence of other protective measures and restrictions”, the EMA said.
The EMA last October approved Comirnaty booster jabs for all people aged 18 and older, followed by a similar decision to back Moderna’s Spikevax shortly afterwards.
It also announced today that it has recommended the approval of the Spikevax vaccine for children aged between six and 11.
Comirnaty has already been approved for use in children aged five and older.
Apart from Pfizer/BioNTech and Moderna’s vaccines, three other anti-Covid shots made by pharmaceuticals AstraZeneca, Johnson & Johnson and Novavax have been approved for use in the EU.
To embed this post, copy the code below on your site
Why? Kids are very low risk and the vaccine does not prevent transmission
@Jim Smith: except physically speaking, they are not exactly kids anymore. Mentally and in our culture, they are, but biologically, they are capable of being parents themselves, and in some cultures they are, so I would be asking why are they treated differently and why the laws were not amended so that they could be vaccinated with the rest of the (Biological) adults
Time to let it go Pfizer!!
have your say